Launched in January 2010 fund after a successful five-year track record in institutional markets, the fund applies Sarasin's proven global thematic investment process to our universe of UK equities as a means of generating repeatable alpha and income growth.The fund seeks to achieve an annualised total return that is 1% in excess of the FTSE All Share (5% capped) benchmark on a rolling 3 year basis.
Name | % Net Assets |
---|---|
BP | 5.3% |
BG Group | 4.7% |
Xstrata | 4.1% |
BT | 4.0% |
BHP Billiton | 4.0% |
Petrofac | 3.8% |
HSBC Holdings | 3.5% |
AstraZeneca | 3.1% |
Barclays Bank | 2.8% |
GlaxoSmithKline | 2.3% |
Key | % Net Assets |
---|---|
BP | 5.3% |
BG Group | 4.7% |
Xstrata | 4.1% |
BT | 4.0% |
Other | 81.9% |
Date | 08-Jun-2023 |
---|---|
NAV | 88.37p |
Currency | GBP |
Change | -0.48p |
% | -0.54% |
YTD change | 88.37p |
YTD % | n/a |
Fund Inception | 28/01/2010 |
---|---|
Fund Manager | n/a |
TER | 1.71 (31-Dec-2013) |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research